AZN logo

AstraZeneca (AZN) Book Value

Annual Book Value

$40.79 B
+$1.64 B+4.20%

December 1, 2024

Summary

Performance

1-Year Change

+4.2%

3-Year Change

+3.87%

5-Year Change

+210.7%

15-Year Change

+172.63%

AZN Book Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

99.27%
AZN annual book value is higher than 99.27% of companies in Healthcare sector

High & Low

All-time High

$40.79 B
AZN annual book value is currently at an all-time high

3-Year Low

$37.04 B
AZN annual book value is currently +10.12% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2024
AZN previous annual earnings announcement was published on Dec 1, 2024

Next Annual Earnings Report Date

N/A
AZN next annual earnings announcement has not yet been scheduled

OtherAZNbalance sheetmetrics:

Annual Retained Earnings

$3.16 B
AZN annual retained earnings is $3.16 billion

Annual Working Capital

-$2.04 B
AZN annual working capital is -$2.04 billion

Annual Total Assets

$104.03 B
AZN annual total assets is $104.03 billion

Annual Total Liabilities

$63.16 B
AZN annual total liabilities is $63.16 billion

Quarterly Book Value

$40.72 B
+$1.21 B+3.05%

September 30, 2024

Summary

Performance

3-Month Change

+3.05%

1-Year Change

+9.47%

3-Year Change

+13.32%

5-Year Change

+13.32%

AZN Quarterly Book Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

99.27%
AZN quarterly book value is higher than 99.27% of companies in Healthcare sector

High & Low

All-time High

$40.72 B
AZN quarterly book value is currently at an all-time high

3-Year Low

$35.13 B
AZN quarterly book value is currently +15.90% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AZN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
AZN next earnings announcement has not yet been scheduled

OtherAZNbalance sheetmetrics:

Quarterly Retained Earnings

$3.14 B
AZN quarterly retained earnings is $3.14 billion

Quarterly Working Capital

-$1.77 B
AZN quarterly working capital is -$1.77 billion

Quarterly Total Assets

$104.92 B
AZN quarterly total assets is $104.92 billion

Quarterly Total Liabilities

$64.12 B
AZN quarterly total liabilities is $64.12 billion

Book Value Formula

Book Value = Total Assets − Total Liabilities

Annual Book Value

$40.79 B
AZN annual book value is $40.79 billion

Annual Total Assets

$104.03 B
AZN annual total assets is $104.03 billion

Annual Total Liabilities

$63.16 B
AZN annual total liabilities is $63.16 billion

AZN Book Value Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+4.2%+9.5%
3 y3 years+3.9%+13.3%
5 y5 years+210.7%+13.3%

AZN Book Value Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+10.1%at high+15.9%
5 y5-yearat high+210.7%at high+277.8%
alltimeall timeat high>+9999.0%at high+1736.4%

AstraZeneca Book Value History

DateAnnualQuarterly
Dec 2024
$40.79 B(+4.2%)
-
Sep 2024
-
$40.72 B(+3.1%)
Jun 2024
-
$39.51 B(+5.5%)
Mar 2024
-
$37.45 B(-4.3%)
Dec 2023
$39.14 B(+5.7%)
$39.14 B(+5.2%)
Sep 2023
-
$37.20 B(-0.5%)
Jun 2023
-
$37.39 B(+4.5%)
Mar 2023
-
$35.79 B(-3.4%)
Dec 2022
$37.04 B(-5.7%)
$37.04 B(+5.4%)
Sep 2022
-
$35.13 B(-2.2%)
Jun 2022
-
$35.93 B(-1.1%)
Mar 2022
-
$36.34 B(-7.5%)
Dec 2021
$39.27 B(+151.4%)
$39.27 B(-1.2%)
Sep 2021
-
$39.74 B(+153.5%)
Jun 2021
-
$15.68 B(+8.6%)
Mar 2021
-
$14.43 B(-7.6%)
Dec 2020
$15.62 B(+19.0%)
$15.62 B(+28.1%)
Sep 2020
-
$12.20 B(-0.3%)
Jun 2020
-
$12.24 B(+13.5%)
Mar 2020
-
$10.78 B(-17.9%)
Dec 2019
$13.13 B(+5.3%)
$13.13 B(+7.9%)
Sep 2019
-
$12.16 B(-10.2%)
Jun 2019
-
$13.55 B(+29.2%)
Mar 2019
-
$10.48 B(-15.9%)
Dec 2018
$12.47 B(-16.7%)
$12.47 B(+4.5%)
Sep 2018
-
$11.94 B(-5.6%)
Jun 2018
-
$12.64 B(-2.1%)
Mar 2018
-
$12.91 B(-13.7%)
Dec 2017
$14.96 B(+0.7%)
$14.96 B(+9.0%)
Sep 2017
-
$13.72 B(+0.5%)
Jun 2017
-
$13.65 B(+5.1%)
Mar 2017
-
$12.99 B(-12.6%)
Dec 2016
$14.85 B(-19.7%)
$14.85 B(+13.6%)
Sep 2016
-
$13.07 B(-3.4%)
Jun 2016
-
$13.53 B(-8.2%)
Mar 2016
-
$14.74 B(-20.3%)
Dec 2015
$18.49 B(-5.8%)
$18.49 B(+6.6%)
Sep 2015
-
$17.35 B(-5.1%)
Jun 2015
-
$18.28 B(+7.9%)
Mar 2015
-
$16.94 B(-13.7%)
Dec 2014
$19.63 B(-15.5%)
$19.63 B(-4.0%)
Sep 2014
-
$20.45 B(-7.2%)
Jun 2014
-
$22.03 B(+2.7%)
Mar 2014
-
$21.45 B(-7.6%)
Dec 2013
$23.22 B(-2.1%)
$23.22 B(-0.1%)
Sep 2013
-
$23.25 B(+0.1%)
Jun 2013
-
$23.22 B(+4.1%)
Mar 2013
-
$22.29 B(-6.1%)
Dec 2012
$23.73 B(+2.1%)
$23.73 B(+7.7%)
Sep 2012
-
$22.04 B(+0.1%)
Jun 2012
-
$22.03 B(+2.4%)
Mar 2012
-
$21.52 B(-7.4%)
Dec 2011
$23.24 B(+0.1%)
$23.24 B(-2.9%)
Sep 2011
-
$23.93 B(+1.4%)
Jun 2011
-
$23.61 B(+5.6%)
Mar 2011
-
$22.35 B(-3.7%)
Dec 2010
$23.21 B
$23.21 B(+4.9%)
DateAnnualQuarterly
Sep 2010
-
$22.13 B(+0.2%)
Jun 2010
-
$22.09 B(+6.6%)
Mar 2010
-
$20.73 B(+0.3%)
Dec 2009
$20.66 B(+29.8%)
$20.66 B(+6.5%)
Sep 2009
-
$19.39 B(+9.0%)
Jun 2009
-
$17.80 B(+15.7%)
Mar 2009
-
$15.38 B(-3.3%)
Dec 2008
$15.91 B(+7.7%)
$15.91 B(-1.2%)
Sep 2008
-
$16.11 B(+0.8%)
Jun 2008
-
$15.97 B(+8.5%)
Mar 2008
-
$14.72 B(-0.4%)
Dec 2007
$14.78 B(-3.4%)
$14.78 B(+1.1%)
Sep 2007
-
$14.61 B(-1.6%)
Jun 2007
-
$14.85 B(+6.8%)
Mar 2007
-
$13.91 B(-9.1%)
Dec 2006
$15.30 B(+12.6%)
$15.30 B(+4.2%)
Sep 2006
-
$14.68 B(-1.5%)
Jun 2006
-
$14.91 B(-2.6%)
Mar 2006
-
$15.30 B(+12.6%)
Dec 2005
$13.60 B(-5.6%)
$13.60 B(+2.4%)
Sep 2005
-
$13.28 B(-1.5%)
Jun 2005
-
$13.48 B(-0.9%)
Mar 2005
-
$13.60 B(-5.6%)
Dec 2004
$14.40 B(+9.3%)
$14.40 B(+8.0%)
Sep 2004
-
$13.33 B(+4.9%)
Jun 2004
-
$12.71 B(+3.1%)
Mar 2004
-
$12.32 B(-6.5%)
Dec 2003
$13.18 B(+18.0%)
$13.18 B(-2.9%)
Sep 2003
-
$13.56 B(+6.5%)
Jun 2003
-
$12.73 B(+4.6%)
Mar 2003
-
$12.17 B(+9.0%)
Dec 2002
$11.17 B(+16.5%)
$11.17 B(-3.3%)
Sep 2002
-
$11.55 B(+4.5%)
Jun 2002
-
$11.06 B(+5.4%)
Mar 2002
-
$10.49 B(+9.5%)
Dec 2001
$9.59 B(+0.6%)
$9.59 B(-4.1%)
Sep 2001
-
$9.99 B(+5.2%)
Jun 2001
-
$9.50 B(-0.3%)
Mar 2001
-
$9.53 B(+0.0%)
Dec 2000
$9.53 B(-7.5%)
$9.53 B(-11.8%)
Sep 2000
-
$10.81 B(+1.6%)
Jun 2000
-
$10.64 B(+11.6%)
Mar 2000
-
$9.53 B(-7.5%)
Dec 1999
$10.30 B(-5.7%)
$10.30 B(-13.3%)
Sep 1999
-
$11.89 B(+6.7%)
Jun 1999
-
$11.14 B(+2.0%)
Dec 1998
$10.93 B(+206.1%)
$10.93 B(+168.9%)
Jun 1998
-
$4.06 B(+13.8%)
Dec 1997
$3.57 B(+2.5%)
$3.57 B(+2.5%)
Dec 1996
$3.48 B(+21.1%)
$3.48 B(+21.1%)
Dec 1995
$2.88 B(+9.2%)
$2.88 B(-2.6%)
Jun 1995
-
$2.95 B(+12.0%)
Dec 1994
$2.63 B(+18.8%)
$2.63 B(+18.8%)
Dec 1993
$2.22 B(+2558.1%)
$2.22 B
Dec 1992
$83.42 M(-89.3%)
-
Dec 1991
$782.16 M(+37.0%)
-
Dec 1990
$570.97 M
-

FAQ

  • What is AstraZeneca annual book value?
  • What is the all time high annual book value for AstraZeneca?
  • What is AstraZeneca annual book value year-on-year change?
  • What is AstraZeneca quarterly book value?
  • What is the all time high quarterly book value for AstraZeneca?
  • What is AstraZeneca quarterly book value year-on-year change?

What is AstraZeneca annual book value?

The current annual book value of AZN is $40.79 B

What is the all time high annual book value for AstraZeneca?

AstraZeneca all-time high annual book value is $40.79 B

What is AstraZeneca annual book value year-on-year change?

Over the past year, AZN annual book value has changed by +$1.64 B (+4.20%)

What is AstraZeneca quarterly book value?

The current quarterly book value of AZN is $40.72 B

What is the all time high quarterly book value for AstraZeneca?

AstraZeneca all-time high quarterly book value is $40.72 B

What is AstraZeneca quarterly book value year-on-year change?

Over the past year, AZN quarterly book value has changed by +$3.52 B (+9.47%)